UNSPSC 12361502: 3,4-methylenedioxyphenyl-2-propanone

A chemical compound consisting of a phenylacetone moiety substituted with a methylenedioxy functional group. It is commonly synthesized from either safrole which, for comparison, is 3-[3,4-(methylenedioxy)phenyl]-2-propene) or its isomer isosafrole via oxidation using the Wacker oxidation or peroxyacid oxidation methods. It is a controlled substance by the US Government on account of its relation to the MDxx chemical class, MDP2P, as well as safrole and isosafrole.

UNSPSC 12361502, 3,4-methylenedioxyphenyl-2-propanone, is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The code's chemical name refers to a controlled precursor compound, yet the opportunities posted under this code soliciting pharmaceutical supplies, naloxone, and pharmacy benefit management services are for legitimate medical and public health products bearing no relationship to that substance. State and local purchasing offices are using this code to tag emergency medical services supplies, opioid reversal agents, pharmacy operations, and related healthcare procurement—none of which matches the controlled-substance precursor the code nominally describes. This is a clear mismatch between the taxonomy assignment and the actual goods and services being bought.

The recent opportunities span cities (Detroit, Tucson, Rio Rancho), counties (Forsyth County Georgia, Seminole County Florida, Williamson County Texas), a state university system (University of Georgia), and a regional health plan (Inland Empire Health Plan in California). Detroit's Office of Contracting and Procurement appears twice, soliciting prescription drug supplies for the Police Department under IFQ 551210 (due October 9, 2026) and medical supplies for vending machines under IFQ 549758 (due September 18, 2026). The City of Tucson Fire Department issued a more complex RFP (260217, due June 24, 2026) for BLS and ALS pharmaceuticals, supplies, vending machines, and software under federal ARPA, HUD, and FTA funding with prevailing wage and Section 3 compliance requirements. Williamson County, Texas posted IFB 26IFB63 for EMS medical and pharmaceutical items (due August 4, 2026), and Seminole County, Florida solicited naloxone and drug deactivation systems (due July 26, 2023). The geographic spread centers on Georgia, Texas, Florida, California, and Arizona, with activity from mid-July through October 2026. Because the code's nominal scope bears no relationship to the medical-supply and pharmacy-services purchases actually being tagged, vendors should treat this code as unreliable for targeting legitimate state and local pharmaceutical and EMS procurement.